DK0604995T3 - Hydroxyamin-N-acylderivater, som har radikalfjernende aktivitet og kan anvendes ved akutte og kroniske patologier forbundet - Google Patents
Hydroxyamin-N-acylderivater, som har radikalfjernende aktivitet og kan anvendes ved akutte og kroniske patologier forbundetInfo
- Publication number
- DK0604995T3 DK0604995T3 DK93121046T DK93121046T DK0604995T3 DK 0604995 T3 DK0604995 T3 DK 0604995T3 DK 93121046 T DK93121046 T DK 93121046T DK 93121046 T DK93121046 T DK 93121046T DK 0604995 T3 DK0604995 T3 DK 0604995T3
- Authority
- DK
- Denmark
- Prior art keywords
- acyl derivatives
- hydroxyamine
- acute
- radical scavenging
- scavenging activity
- Prior art date
Links
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 title abstract 2
- 230000007170 pathology Effects 0.000 title abstract 2
- 230000002292 Radical scavenging effect Effects 0.000 title 1
- 230000001154 acute effect Effects 0.000 title 1
- 230000001684 chronic effect Effects 0.000 title 1
- IXNVNKMGHGWCFY-UHFFFAOYSA-N 3,4-dihydro-2h-benzo[h]chromene Chemical compound C1=CC2=CC=CC=C2C2=C1CCCO2 IXNVNKMGHGWCFY-UHFFFAOYSA-N 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- HBEDSQVIWPRPAY-UHFFFAOYSA-N dihydro-benzofuran Natural products C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI922997A IT1256264B (it) | 1992-12-31 | 1992-12-31 | N-acilderivati di idrossiammine dotati di attivita' scavenger ed utilizzabili nelle patologie acute e croniche correlate a fenomeni di perossidazione ed infiammazione |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0604995T3 true DK0604995T3 (da) | 1999-06-21 |
Family
ID=11364566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93121046T DK0604995T3 (da) | 1992-12-31 | 1993-12-29 | Hydroxyamin-N-acylderivater, som har radikalfjernende aktivitet og kan anvendes ved akutte og kroniske patologier forbundet |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5480645A (da) |
| EP (1) | EP0604995B1 (da) |
| JP (1) | JPH06234756A (da) |
| AT (1) | ATE171703T1 (da) |
| CA (1) | CA2112611A1 (da) |
| DE (1) | DE69321332T2 (da) |
| DK (1) | DK0604995T3 (da) |
| ES (1) | ES2124765T3 (da) |
| IT (1) | IT1256264B (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6017953A (en) * | 1993-12-28 | 2000-01-25 | Allergan Sales, Inc. | Thromboxane ligands |
| ATE262334T1 (de) * | 1996-02-02 | 2004-04-15 | Merck & Co Inc | Antidiabetisches mittel |
| US5859051A (en) * | 1996-02-02 | 1999-01-12 | Merck & Co., Inc. | Antidiabetic agents |
| US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
| US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
| US6703384B2 (en) * | 1998-09-23 | 2004-03-09 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| WO2000046183A1 (en) | 1999-02-08 | 2000-08-10 | Checkpoint Genetics, Inc. | N-substituted amino acids, antioxidant pharmaceutical compositions containing same and methods using same |
| KR100847678B1 (ko) * | 2000-02-11 | 2008-07-23 | 리서치 디벨럽먼트 파운데이션 | 토코페롤, 토코트리에놀, 다른 크로만 및 측쇄 유도체, 및이들의 용도 |
| US6299865B1 (en) * | 2000-05-02 | 2001-10-09 | Peter Styczynski | Reduction of hair growth |
| US6653346B1 (en) | 2002-02-07 | 2003-11-25 | Galileo Pharmaceuticals, Inc. | Cytoprotective benzofuran derivatives |
| US7078541B2 (en) * | 2002-02-07 | 2006-07-18 | Galileo Pharmaceuticals, Inc. | Benzofuran derivatives |
| EP1673467A4 (en) * | 2003-10-15 | 2008-01-23 | Matsushita Electric Ind Co Ltd | SYSTEMS AND METHOD FOR EVALUATING NEURONAL DEGENERATION |
| FR2875803B1 (fr) * | 2004-09-24 | 2006-11-24 | Catalys Sarl | Preparation de composes phenol-amides a proprietes antioxydantes |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5594382A (en) * | 1979-01-11 | 1980-07-17 | Eisai Co Ltd | Chroman-based compound and cholestrol lowering drug comprising it |
| CA2002649C (en) * | 1988-11-14 | 2000-06-06 | Margaret Petty | Cardioprotective tocopherol analogs |
| JPH02215778A (ja) * | 1989-02-14 | 1990-08-28 | Kuraray Co Ltd | ３，４―ジヒドロ―２ｈ―ベンゾピラン誘導体及びその医薬用途 |
| IT1231341B (it) * | 1989-08-18 | 1991-11-28 | Foscama Biomed Chim Farma | 2,3 diidro 5 ossi 4,6,7 trimetilbenzofurani 2 (rs) sostituiti, utili come farmaci antiossidanti con proprieta' mucoregolatrici e antiischemiche. |
| FR2676056B1 (fr) * | 1991-05-03 | 1993-07-16 | Adir | Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| HUT68926A (en) * | 1992-04-06 | 1995-08-28 | Merrell Dow Phyarmaceuticals I | 2,3-dihydro-benzofuranol derivatives |
-
1992
- 1992-12-31 IT ITMI922997A patent/IT1256264B/it active IP Right Grant
-
1993
- 1993-12-28 JP JP5350273A patent/JPH06234756A/ja active Pending
- 1993-12-29 AT AT93121046T patent/ATE171703T1/de not_active IP Right Cessation
- 1993-12-29 DK DK93121046T patent/DK0604995T3/da active
- 1993-12-29 DE DE69321332T patent/DE69321332T2/de not_active Expired - Fee Related
- 1993-12-29 ES ES93121046T patent/ES2124765T3/es not_active Expired - Lifetime
- 1993-12-29 US US08/175,233 patent/US5480645A/en not_active Expired - Fee Related
- 1993-12-29 EP EP93121046A patent/EP0604995B1/en not_active Expired - Lifetime
- 1993-12-30 CA CA002112611A patent/CA2112611A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IT1256264B (it) | 1995-11-29 |
| EP0604995A1 (en) | 1994-07-06 |
| CA2112611A1 (en) | 1994-07-01 |
| ES2124765T3 (es) | 1999-02-16 |
| ITMI922997A0 (it) | 1992-12-31 |
| ITMI922997A1 (it) | 1994-07-01 |
| DE69321332D1 (de) | 1998-11-05 |
| EP0604995B1 (en) | 1998-09-30 |
| DE69321332T2 (de) | 1999-04-22 |
| JPH06234756A (ja) | 1994-08-23 |
| US5480645A (en) | 1996-01-02 |
| ATE171703T1 (de) | 1998-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0604995T3 (da) | Hydroxyamin-N-acylderivater, som har radikalfjernende aktivitet og kan anvendes ved akutte og kroniske patologier forbundet | |
| NO157020C (no) | Analogifremgangsmte ved fremstilling av terapeutisk aktive 3,20-dioxo-1,4-pregnadien-17alfa-ol-17-aromatiske heterocykliske carboxylater. | |
| ES2171543T3 (es) | Composiciones administrables topicamente que contienen derivados del acido 3-benzoilfenilacetico para el tratamiento de trastornos inflamatorios oftalmicos. | |
| ATE142877T1 (de) | Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie | |
| JPS5646809A (en) | Glycolic acid oxidase inhibitor of 44*substituted thiazolyl**33hydroxyy33 pyrrolinee2*55dione | |
| MC2078A1 (fr) | Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires | |
| DE3875286D1 (de) | Essentielle fettsaeure enthaltende zusammensetzungen. | |
| DE69312579D1 (de) | Arzneimittel zur Behandlung von Vulva-Dystrophie oder Vaginaltrockenheit | |
| ATE109001T1 (de) | Mittel zur stimulierung der tränensekretion. | |
| ES2063060T3 (es) | Benzamida contra enfermedades cognoscitivas. | |
| ATE72985T1 (de) | Verwendung von bisguanide enthaltenden zusammensetzungen gegen eier des madenwurms. | |
| DK0549666T3 (da) | Nye aminobenzosultamderivater og deres anvendelse som lipoxygenaseinhibitorer | |
| ES2075272T5 (es) | Composiciones dermatologicas conteniendo acido cis-urocanico. | |
| GR3029489T3 (en) | Use of leflunomid for the inhibition of interleukin 8. | |
| ATE142491T1 (de) | Mittel zur behandlung des atopischen ekzems und anderen entzündlichen hautkrankheiten | |
| GR3006674T3 (da) | ||
| FI944656A0 (fi) | Uudet kardioprotektiivset aineet | |
| ATE229336T1 (de) | Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern | |
| NO942212L (no) | 13,14-dihydro-PGF2 | |
| GR3029492T3 (en) | Use of leflunomid for the inhibition of interleukin 1 alpha. | |
| ITPD960038V0 (it) | Associazione di porfirina cationica e sorgente luminosa coerente o noncoerente per il trattamento di infezioni microbiche dell'endodonto e del periimpianto | |
| IT8019044A0 (it) | Derivati di acidi carbossilici conproprieta'terapeutiche per il trattamento di malattie coronariche, della arteriosclerosi e di forme infiammatorie |